8-(Phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide

ID: ALA1094401

PubChem CID: 46223564

Max Phase: Preclinical

Molecular Formula: C16H14N6O

Molecular Weight: 306.33

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1n[nH]c2c1CCc1cnc(Nc3ccccc3)nc1-2

Standard InChI:  InChI=1S/C16H14N6O/c17-15(23)14-11-7-6-9-8-18-16(19-10-4-2-1-3-5-10)20-12(9)13(11)21-22-14/h1-5,8H,6-7H2,(H2,17,23)(H,21,22)(H,18,19,20)

Standard InChI Key:  ZYQXOZKYXADECC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -1.9620   -1.9771    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9632   -2.8037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2491   -3.2162    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2509   -1.5649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5362   -1.9736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5328   -2.8012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8940   -1.9677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1749   -1.5545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8974   -2.7953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1807   -3.2110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3545   -4.0212    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1788   -4.1062    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5142   -3.3486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2228   -2.9304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9405   -3.3357    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2149   -2.1063    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6773   -3.2152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3907   -2.8026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3897   -1.9785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1022   -1.5660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8172   -1.9775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8152   -2.8060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1021   -3.2148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
  3  6  2  0
 13 14  1  0
  1  2  2  0
 14 15  1  0
  5  8  1  0
 14 16  2  0
  6 10  1  0
  2 17  1  0
  9  7  1  0
 17 18  1  0
  7  8  1  0
 18 19  2  0
  9 10  2  0
 19 20  1  0
  5  4  2  0
 20 21  2  0
  4  1  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 23 18  1  0
M  END

Associated Targets(Human)

CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 306.33Molecular Weight (Monoisotopic): 306.1229AlogP: 1.81#Rotatable Bonds: 3
Polar Surface Area: 109.58Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 10.27CX Basic pKa: 1.81CX LogP: 2.23CX LogD: 2.22
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.68Np Likeness Score: -1.14

References

1. Beria I, Ballinari D, Bertrand JA, Borghi D, Bossi RT, Brasca MG, Cappella P, Caruso M, Ceccarelli W, Ciavolella A, Cristiani C, Croci V, De Ponti A, Fachin G, Ferguson RD, Lansen J, Moll JK, Pesenti E, Posteri H, Perego R, Rocchetti M, Storici P, Volpi D, Valsasina B..  (2010)  Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.,  53  (9): [PMID:20397705] [10.1021/jm901713n]

Source